TARDBP and amyotrophic lateral sclerosis: However, only a limited number of studies describe the presence of phosphorylated TDP-43 aggregates in ALS muscle and the fraction of ALS patients with muscular TDP-43 aggregates is around 30% (Cykowski et al., 2018; Mori et al., 2019).